Our TMS team, directed by Dr. Erin Amato, MD, is dedicated to providing the best in diagnosis and treatment to put you on the path to healing and enriched living. At Montana Psychiatry & Brain Health Center, we are dedicated to serving the mental health needs of children and adults in our region. We aim to provide compassionate, thoughtful, and comprehensive care by using an integrated approach that focuses on biological, psychological, and social factors that are unique to each patient. We strive for excellence in our delivery of care and offer cutting edge treatments and interventions to restore hope and quality of life for patients and families.


May people with depression have suffered for years and have not found the relief they seek from medications or therapy. Many continue to struggle with depression when they experience multiple side effects to medications. The Brainsway Deep TMS technology offers a safe, clinically-proven and effective treatment for depression that is conveniently provided in an outpatient setting without need for anesthesia or hospitalization.

“Brainsway* is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. Brainsway’s flagship technology is Deep TMS, or Deep Transcranial Magnetic Stimulation, which launches a new era in brain disorder treatment.

Brainsway’s Transcranial Magnetic Stimulation technology is based on patents filed by the U.S. National Institutes of Health (NIH), and by the company. The company holds an exclusive license from the NIH for the patent and for Deep TMS technology.

Brainsway’s Deep TMS is FDA cleared for treating depressive episodes in adult patients suffering from Major Depressive Disorder, who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode (FDA 510(k) No. K122288).” -Brainsway.com

Dr. Erin Amato, MD, was raised in Billings, Montana and attended medical school at the University of Nevada School of Medicine. Upon graduation from medical school, Dr. Amato was awarded the Lillian Orchow Prize for Outstanding Student in Psychiatry and was designated as an AMA Foundation Rock Sleyster Scholar.

She completed her internship and residency in general psychiatry at Long Island Jewish Medical Center-Zucker Hillside Hospital in Glen Oaks, New York. She then pursued fellowship training in child and adolescent psychiatry through the NSLIJHS-Albert Einstein College of Medicine program in New Hyde Park, NY. She served as the chief fellow during her second year of the fellowship and was awarded the Clinical Excellence Award upon completion of her program.

After finishing her child psychiatry fellowship, Dr. Amato returned to Billings with her family to start clinical practice. In addition to her private practice through Montana Psychiatry, she has worked with AWARE and Yellowstone Boys and Girls Ranch to provide mental health services to children and adolescents in the region. Dr. Amato is involved in regional and national activities for the American Academy of Child and Adolescent Psychiatry and has served as the Assembly Delegate for the Big Sky Regional Organization of AACAP since 2010.

Dr. Amato believes that early intervention is critical when people are affected by emotional, behavioral, cognitive and learning disorders. Especially in cases of children and adolescents, early diagnosis and treatment of psychiatric disorders is essential in promoting healthy development.

Dr. Amato has received training in TMS and other Brain Stimulation techniques as the Brain Stimulation Laboratory of Medical University of South Carolina. She is also a member of the Clinical TMS Society. She is committed to exploring cutting edge treatments for depression and other mental health conditions and is excited to now be able to offer TMS to patients in the region.

Dr. Amato has double board certification in general psychiatry and child and adolescent psychiatry by the American Board of Psychiatry and Neurology.